サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1435120

API中間体市場：タイプ、原料、用途、エンドユーザー別-2024-2030年の世界予測

API Intermediates Market by Type (Bulk Drug Intermediates, Chemical Intermediates), Raw Material (Carbonyl, Chloro, Nitrile), Application, End User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 199 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
API中間体市場：タイプ、原料、用途、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 199 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

API中間体市場規模は2023年に1,786億3,000万米ドルと推定され、2024年には1,926億5,000万米ドルに達し、CAGR 7.85%で2030年には3,032億3,000万米ドルに達すると予測されます。

API中間体の世界市場

主な市場の統計
基準年[2023］ 1,786億3,000万米ドル
予測年[2024] 1,926億5,000万米ドル
予測年 [2030] 3,032億3,000万米ドル
CAGR（%） 7.85%
API中間体 Market-IMG1

API（Active Pharmaceutical Ingredients）中間体は、APIの製造においてビルディングブロックとして機能する化学化合物です。APIは医薬品に含まれる生物学的に活性な化合物で、製造される医薬品の望ましい治療効果を可能にします。API中間体は、原薬の製造につながる化学反応の出発物質または主要成分として作用します。API中間体の品質を確保することは、医薬品の有効性と安全性に関する規制基準を満たしながら、効果的な医薬品を製造するために必要です。API中間体のニーズが拡大している背景には、様々なジェネリック医薬品の製造を必要とする慢性疾患の流行や、バイオ医薬品の製造活動を促進する政府の取り組みがあります。希少疾病の増加に伴い、近年では特殊原薬の製造がますます重視されるようになっています。しかし、API中間体の複雑な調達や、原薬の安全性と品質の維持に関連する規制上の懸念が、市場の効率的な拡大に大きな影響を与えています。市場関係者は、より安全な製造方法を確保するため、API中間体の合成・加工方法の高度化に絶えず取り組んでいます。また、原薬製造に特化した製造受託機関も大幅に増加しており、市場拡大の好機が広がっています。さらに、人工知能（AI）や機械学習（ML）などのデジタル技術の進歩を活用することで、新薬の中間体候補をより効果的に予測し、調査プロセスを合理化することもできます。

地域別の洞察

南北アメリカ市場は、API中間体に関連する研究開発活動への投資が大幅に増加していることが特徴です。この地域の大手製薬会社は、革新的な研究や複雑な原薬をコスト効率よく生産するための技術向上に取り組む中小企業との合併、買収、提携を通じて、その能力を拡大することに注力しています。米国の食品医薬品局（FDA）とカナダのカナダ保健省が主導する厳格な規制の枠組みは、API中間体の高品質基準を保証しています。APACはそのコスト競争力のある製造能力により、API中間体市場において重要なプレーヤーとして台頭してきました。この成長に貢献している主な国はインドと中国で、医薬品輸出を促進する政府の政策が後押ししています。同地域では、先進地域での需要拡大を取り込むため、技術やトレーニングへの投資を通じて品質基準の向上に注力する一方、主要企業間の提携や原薬のバルク生産も行われています。欧州は伝統的に、有機合成化学プロセスにおける強力な専門知識を維持することを可能にするAPI中間体を生産するための化学合成に重点を置いてきました。ドイツ、フランス、英国などの成熟した市場は、欧州医薬品庁（EMA）が管理する厳格な規制によって特徴付けられ、高品質の基準が保証されています。欧州企業は、確立されたインフラと熟練した労働力の利点を活用して、原薬中間体製造の世界クライアントを誘致しており、この地域における活気ある調査・製造受託サービス（CRAMS）エコシステムの出現につながっています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはAPI中間体市場の評価において極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、API中間体市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-API中間体市場の市場規模および予測は？

2-API中間体市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-API中間体市場における技術動向と規制の枠組みは？

4-API中間体市場における主要ベンダーの市場シェアは？

5-API中間体市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 慢性疾患の蔓延とジェネリック医薬品の必要性
      • バイオ医薬品の製造活動を促進する政府の取り組み
      • 希少疾患および希少疾患の治療のための特殊APIの採用の増加
    • 抑制要因
      • API中間体の複雑な調達と知的財産に関する懸念
    • 機会
      • API中間体の合成と処理の進歩
      • 原薬製造に特化した受託製造組織の台頭
    • 課題
      • API中間体の安全性と品質に関する規制の複雑さ
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 API中間体市場：タイプ別

  • 原薬中間体
  • 化学中間体

第7章 API中間体市場：原材料別

  • カルボニル
  • クロロ
  • ニトリル
  • ニトロ

第8章 API中間体市場：用途別

  • 鎮痛剤
  • 抗感染症薬
  • 抗がん剤
  • 抗糖尿病薬
  • 心臓血管薬

第9章 API中間体市場：エンドユーザー別

  • バイオテクノロジー企業および製薬会社
  • CMO
  • 調査

第10章 南北アメリカのAPI中間体市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域のAPI中間体市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカのAPI中間体市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析
    • 合併・買収
    • 投資、資金調達
    • 受賞・表彰・拡大

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Aarti Pharmalabs Limited
    • Actylis
    • Alzchem Group
    • API Corporation by UBE Corp.
    • Atul Ltd.
    • Aurobindo Pharma
    • BASF SE
    • Cambrex Corp.
    • Cation Pharma
    • Divi's Laboratories Limited
    • Dr. Reddy's Laboratories Ltd.
    • Espee Group
    • Evonik Industries AG
    • Flamma Group
    • Hikal Ltd.
    • Kaneka Corporation
    • Levachem Company Ltd.
    • Lupin Ltd.
    • Nectar Lifesciences Ltd.
    • Noah Chemicals
    • Pfizer Inc.
    • Proviron Holding NV
    • Sandoo Pharmaceuticals and Chemicals Co., Ltd.
    • Sandoz International GmbH by Novartis AG
    • Sanofi
    • Sarex
    • Shree Ganesh Remedies Ltd.
    • Sumitomo Chemical Co., Ltd.
    • Vertellus
    • ZCL Chemicals Ltd. by Advent International
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. API INTERMEDIATES MARKET RESEARCH PROCESS
  • FIGURE 2. API INTERMEDIATES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. API INTERMEDIATES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. API INTERMEDIATES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. API INTERMEDIATES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. API INTERMEDIATES MARKET DYNAMICS
  • FIGURE 7. API INTERMEDIATES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. API INTERMEDIATES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2023 VS 2030 (%)
  • FIGURE 10. API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. API INTERMEDIATES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. API INTERMEDIATES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES API INTERMEDIATES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES API INTERMEDIATES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. API INTERMEDIATES MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. API INTERMEDIATES MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. API INTERMEDIATES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. API INTERMEDIATES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL API INTERMEDIATES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. API INTERMEDIATES MARKET SIZE, BY BULK DRUG INTERMEDIATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. API INTERMEDIATES MARKET SIZE, BY CHEMICAL INTERMEDIATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 9. API INTERMEDIATES MARKET SIZE, BY CARBONYL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. API INTERMEDIATES MARKET SIZE, BY CHLORO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. API INTERMEDIATES MARKET SIZE, BY NITRILE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. API INTERMEDIATES MARKET SIZE, BY NITRO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. API INTERMEDIATES MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. API INTERMEDIATES MARKET SIZE, BY ANTI-INFECTIVE DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. API INTERMEDIATES MARKET SIZE, BY ANTICANCER DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. API INTERMEDIATES MARKET SIZE, BY ANTIDIABETIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. API INTERMEDIATES MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. API INTERMEDIATES MARKET SIZE, BY BIOTECH & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. API INTERMEDIATES MARKET SIZE, BY CMO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. API INTERMEDIATES MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES API INTERMEDIATES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. API INTERMEDIATES MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 192. API INTERMEDIATES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. API INTERMEDIATES MARKET LICENSE & PRICING
目次
Product Code: MRR-CF699CF4142B

[199 Pages Report] The API Intermediates Market size was estimated at USD 178.63 billion in 2023 and expected to reach USD 192.65 billion in 2024, at a CAGR 7.85% to reach USD 303.23 billion by 2030.

Global API Intermediates Market

KEY MARKET STATISTICS
Base Year [2023] USD 178.63 billion
Estimated Year [2024] USD 192.65 billion
Forecast Year [2030] USD 303.23 billion
CAGR (%) 7.85%
API Intermediates Market - IMG1

API (Active Pharmaceutical Ingredients) intermediates are chemical compounds that cater as building blocks in the production of APIs. APIs are biologically active compounds in pharmaceutical drugs that enable the desired therapeutic effect of the drug produced. API intermediates act as the starting materials or key components in the chemical reactions that lead to the making of APIs. Ensuring the quality of API intermediates is necessary to create an effective medication while meeting the regulatory standards for drug efficacy and safety. The expanding need for API intermediates has been driven by the prevalence of chronic diseases demanding the production of various generic drugs and government initiatives promoting biopharmaceutical manufacturing activities. With the rise in cases of orphan and rare diseases, recent years have observed an increasing emphasis on the manufacturing of specialty APIs. However, complicated sourcing of API intermediates and regulatory concerns associated with maintaining the safety and quality of APIs significantly impact the efficient expansion of the market. Market players are constantly working on elevating the synthesizing and processing methods of API intermediates to ensure a safer production method. There has also been a major increase in the number of contract manufacturing organizations specializing in API production, which has created better opportunities for market enlargement. Moreover, leveraging advances in digital technologies such as artificial intelligence (AI) and machine learning (ML) could also help streamline research processes by predicting potential intermediates for novel drugs more effectively.

Regional Insights

The Americas market is characterized by a substantial increase in investments toward R&D activities related to the API intermediates. Major regional pharmaceutical companies focus on expanding their capabilities through mergers, acquisitions, or collaborations with smaller firms engaged in innovative research and in technology upgradation for the cost-effective production of complex APIs. Strict regulatory frameworks led by the U.S. Food & Drug Administration (FDA) in the United States and Health Canada in Canada ensure high-quality standards for API intermediates. APAC has emerged as a vital player in the API intermediates market due to its cost-competitive manufacturing capabilities. Major countries contributing to this growth are India and China, with supportive government policies that promote pharmaceutical exports. The region also witnesses collaborations among key players or bulk API production while focusing on improving quality standards through investments in technology and training to capture growing demand in developed regions. Europe has been traditionally focusing on chemical synthesis for producing API intermediates which enables them to maintain strong expertise in synthetic organic chemistry processes. Mature markets such as Germany, France, and the United Kingdom are characterized by strict regulations governed by the European Medicines Agency (EMA), ensuring high-quality standards. European companies are leveraging the advantages of their well-established infrastructure and skilled workforce to attract global clients for API intermediate manufacturing, leading to the emergence of a vibrant contract research and manufacturing services (CRAMS) ecosystem in the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the API Intermediates Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the API Intermediates Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the API Intermediates Market, highlighting leading vendors and their innovative profiles. These include Aarti Pharmalabs Limited, Actylis, Alzchem Group, API Corporation by UBE Corp., Atul Ltd., Aurobindo Pharma, BASF SE, Cambrex Corp., Cation Pharma, Divi's Laboratories Limited, Dr. Reddy's Laboratories Ltd., Espee Group, Evonik Industries AG, Flamma Group, Hikal Ltd., Kaneka Corporation, Levachem Company Ltd., Lupin Ltd., Nectar Lifesciences Ltd., Noah Chemicals, Pfizer Inc., Proviron Holding NV, Sandoo Pharmaceuticals and Chemicals Co., Ltd., Sandoz International GmbH by Novartis AG, Sanofi, Sarex, Shree Ganesh Remedies Ltd., Sumitomo Chemical Co., Ltd., Vertellus, and ZCL Chemicals Ltd. by Advent International.

Market Segmentation & Coverage

This research report categorizes the API Intermediates Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Bulk Drug Intermediates
    • Chemical Intermediates
  • Raw Material
    • Carbonyl
    • Chloro
    • Nitrile
    • Nitro
  • Application
    • Analgesics
    • Anti-Infective Drugs
    • Anticancer Drugs
    • Antidiabetic Drugs
    • Cardiovascular Drugs
  • End User
    • Biotech & Pharmaceutical Companies
    • CMO
    • Research Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the API Intermediates Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the API Intermediates Market?

3. What are the technology trends and regulatory frameworks in the API Intermediates Market?

4. What is the market share of the leading vendors in the API Intermediates Market?

5. Which modes and strategic moves are suitable for entering the API Intermediates Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. API Intermediates Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic diseases and need for generic drugs
      • 5.1.1.2. Government initiatives promoting biopharmaceutical manufacturing activities
      • 5.1.1.3. Increased adoption of specialty APIs for rare and orphan disease treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Complicated sourcing of API intermediates and intellectual property concerns
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in synthesizing and processing of API intermediates
      • 5.1.3.2. Rise of contract manufacturing organizations specializing in API production
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory complexity concerning the safety and quality of API intemediates
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. API Intermediates Market, by Type

  • 6.1. Introduction
  • 6.2. Bulk Drug Intermediates
  • 6.3. Chemical Intermediates

7. API Intermediates Market, by Raw Material

  • 7.1. Introduction
  • 7.2. Carbonyl
  • 7.3. Chloro
  • 7.4. Nitrile
  • 7.5. Nitro

8. API Intermediates Market, by Application

  • 8.1. Introduction
  • 8.2. Analgesics
  • 8.3. Anti-Infective Drugs
  • 8.4. Anticancer Drugs
  • 8.5. Antidiabetic Drugs
  • 8.6. Cardiovascular Drugs

9. API Intermediates Market, by End User

  • 9.1. Introduction
  • 9.2. Biotech & Pharmaceutical Companies
  • 9.3. CMO
  • 9.4. Research Laboratories

10. Americas API Intermediates Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific API Intermediates Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa API Intermediates Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Merger & Acquisition
      • 13.3.1.1. Sigachi Industries Forays into API business, Acquires Majority Stake in Trimax Bio Sciences
    • 13.3.2. Investment & Funding
      • 13.3.2.1. FLAMMA to Invest USD 200 Million Over the Next 3 Years
    • 13.3.3. Award, Recognition, & Expansion
      • 13.3.3.1. Boehringer Ingelheim and German Chancellor Olaf Scholz Lay The Foundation Stone for 285 million EUR Innovation Center

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Aarti Pharmalabs Limited
    • 14.1.2. Actylis
    • 14.1.3. Alzchem Group
    • 14.1.4. API Corporation by UBE Corp.
    • 14.1.5. Atul Ltd.
    • 14.1.6. Aurobindo Pharma
    • 14.1.7. BASF SE
    • 14.1.8. Cambrex Corp.
    • 14.1.9. Cation Pharma
    • 14.1.10. Divi's Laboratories Limited
    • 14.1.11. Dr. Reddy's Laboratories Ltd.
    • 14.1.12. Espee Group
    • 14.1.13. Evonik Industries AG
    • 14.1.14. Flamma Group
    • 14.1.15. Hikal Ltd.
    • 14.1.16. Kaneka Corporation
    • 14.1.17. Levachem Company Ltd.
    • 14.1.18. Lupin Ltd.
    • 14.1.19. Nectar Lifesciences Ltd.
    • 14.1.20. Noah Chemicals
    • 14.1.21. Pfizer Inc.
    • 14.1.22. Proviron Holding NV
    • 14.1.23. Sandoo Pharmaceuticals and Chemicals Co., Ltd.
    • 14.1.24. Sandoz International GmbH by Novartis AG
    • 14.1.25. Sanofi
    • 14.1.26. Sarex
    • 14.1.27. Shree Ganesh Remedies Ltd.
    • 14.1.28. Sumitomo Chemical Co., Ltd.
    • 14.1.29. Vertellus
    • 14.1.30. ZCL Chemicals Ltd. by Advent International
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing